MedTrace Logo

Micro RNA Genetic Signature in NSCLC Egyptian Patients

NCT02445924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-10-24

No results posted yet for this study

Summary

This study will be carried out on 40 subjects at Chest department Tanta university hospital

The subjects will be classified into three groups:

* Group I: will include ten non smoker volunteers (control group I).
* GroupII: will include ten smoker volunteers (control groupII).
* Group III: will include twenty NSCLC patients confirmed by pathological examination of bronchoalveolar examination (BAL), brush and/or biopsy.

Conditions

Sponsors & Collaborators

  • Adel Salah Bediwy

    lead OTHER

Principal Investigators

  • Amgad A Farahat, MD · Chest Department, Faculty of Medicine, Tanta University

  • Ayman H Abd El-Zaher, MD · Chest Department, Faculty of Medicine, Tanta University

  • Said M Hammad, MD · Clinical Pathology Department, Faculty of Medicine, Tanta University

  • Adel S Bediwy, MD · Chest Department, Faculty of Medicine, Tanta University

  • Ayman A Al Saka, MD · Pathology Department, Faculty of Medicine, Tanta University

  • Samar A Mansour, Master · Chest Department, Faculty of Medicine, Tanta University

  • Abdel-Aziz A Zidan, PHD · Director of Genomics and Proteomics Unit, Center of Excellence in Cancer Research, Tanta University

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-01-31
Completion
2016-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02445924 on ClinicalTrials.gov